Bowel disease: Prospective comparison of CT and 1.5‐T pre‐ and postcontrast MR imaging with T1‐weighted fat‐suppressed and breath‐hold FLASH sequences

CT of the gastrointestinal tract: principles and interpretation.

1991 • 239 citations

First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.

1990 • 177 citations

Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging

1989 • 158 citations

Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings.

1989 • 120 citations

Liver and pancreas: improved spin-echo T1 contrast by shorter echo time and fat suppression at 1.5 T.

1991 • 119 citations

Recurrent rectal cancer: diagnosis with MR imaging versus CT.

1988 • 115 citations

Preoperative staging of rectal carcinoma with MR imaging: surgical and histopathologic correlation.

1990 • 111 citations

MR imaging of the gastrointestinal tract: value of Gd-DTPA

1988 • 107 citations

Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.

1991 • 94 citations

Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans

1987 • 91 citations

Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy.

1991 • 85 citations

MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis

1989 • 81 citations

Gastrointestinal tract: dynamic MR studies with echo-planar imaging.

1989 • 69 citations

Chemical shift imaging with paramagnetic contrast material enhancement for improved lesion depiction.

1989 • 64 citations

MR imaging in sclerosing mesenteritis.

1991 • 49 citations

Intra- and paraorbital lesions: value of fat-suppression MR imaging with paramagnetic contrast enhancement.

1991 • 38 citations

Crohn disease in the pediatric patient: CT evaluation.

1991 • 32 citations